SOFA vs APACHE II: Choosing the Right ICU Scoring System

Compare SOFA Score (dynamic daily assessment) and APACHE II (admission severity). Learn when to use each ICU scoring system for sepsis, mortality prediction, and organ dysfunction tracking.

By Online Medical Tools Editorial TeamPublished Invalid Date

SOFA vs APACHE II: Choosing the Right ICU Scoring System

Quick Answer: SOFA (Sequential Organ Failure Assessment) is a dynamic scoring system calculated daily to track organ dysfunction changes over time—best for monitoring sepsis and multi-organ failure progression. APACHE II (Acute Physiology and Chronic Health Evaluation) is a static scoring system calculated once in the first 24 hours to predict mortality risk at ICU admission—best for general ICU prognostication and research. Use SOFA for ongoing sepsis monitoring and trending organ function. Use APACHE II for admission severity assessment and mortality prediction across all ICU patient types.

Side-by-Side Comparison

| Feature | SOFA Score | APACHE II Score | |---------|-----------|----------------| | Full name | Sequential Organ Failure Assessment | Acute Physiology and Chronic Health Evaluation II | | Primary purpose | Track organ dysfunction changes over time | Predict mortality at ICU admission | | Assessment timing | Daily (serial measurements) | Single assessment (first 24 hours) | | Scoring approach | Dynamic (tracks trends) | Static (one-time snapshot) | | Score range | 0-24 | 0-71 | | Organ systems assessed | 6 systems (respiration, coagulation, liver, cardiovascular, CNS, renal) | 12 physiological variables | | Includes age | No | Yes (+0 to +6 points) | | Includes chronic health | No | Yes (+2 to +5 points) | | Complexity | Simple (6 items, 0-4 each) | Complex (34 variables) | | Time to calculate | 2-3 minutes (if data available) | 5-10 minutes (requires multiple data points) | | Best for sepsis | ✅ Yes (Sepsis-3 criteria use SOFA) | Moderate (general ICU tool) | | Best for mortality prediction | Good (when serial scores used) | ✅ Excellent (validated across ICU types) | | Best for monitoring trends | ✅ Yes (designed for serial use) | No (single assessment) | | Clinical use | Sepsis diagnosis (qSOFA, SOFA), organ dysfunction monitoring | Admission severity, mortality prediction, research benchmarking | | Sepsis-3 definition | SOFA ≥2 point increase = organ dysfunction | Not used in Sepsis-3 | | ICU applicability | All ICU patients, particularly sepsis | All ICU patients (medical, surgical, trauma) | | Evidence base | Strong for sepsis, moderate for general ICU | Strong for general ICU mortality |

SOFA Score: Sequential Organ Failure Assessment

What It Measures

SOFA is a dynamic ICU scoring system that tracks organ dysfunction across 6 organ systems. It's calculated daily to monitor how patients are improving or deteriorating during their ICU stay.

SOFA was developed in 1996 by the European Society of Intensive Care Medicine (ESICM) specifically to describe organ dysfunction (not mortality prediction, though mortality correlates with score).

The 6 Organ Systems (0-4 Points Each)

| Organ System | Score 0 (Normal) | Score 1 | Score 2 | Score 3 | Score 4 (Worst) | |--------------|------------------|---------|---------|---------|----------------| | Respiration (PaO₂/FiO₂ ratio) | ≥400 | <400 | <300 | <200 with ventilation | <100 with ventilation | | Coagulation (Platelets) | ≥150 × 10³/µL | <150 | <100 | <50 | <20 | | Liver (Bilirubin) | <1.2 mg/dL | 1.2-1.9 | 2.0-5.9 | 6.0-11.9 | >12.0 | | Cardiovascular (MAP or vasopressors) | MAP ≥70 mmHg | MAP <70 | Dopamine ≤5 or dobutamine (any dose) | Dopamine 5.1-15 or epi/norepi ≤0.1 | Dopamine >15 or epi/norepi >0.1 | | CNS (Glasgow Coma Scale) | GCS 15 | GCS 13-14 | GCS 10-12 | GCS 6-9 | GCS <6 | | Renal (Creatinine or urine output) | Creatinine <1.2 | 1.2-1.9 | 2.0-3.4 | 3.5-4.9 or UOP <500 mL/day | >5.0 or UOP <200 mL/day |

Total SOFA Score: 0-24 (sum of all 6 organ system scores)

Vasopressor doses are in mcg/kg/min for at least 1 hour.

How SOFA is Used

1. Sepsis-3 Diagnosis:

SOFA ≥2 point increase from baseline = organ dysfunction due to sepsis
qSOFA (quick SOFA) used for bedside screening: respiratory rate ≥22, altered mentation, SBP ≤100

2. Daily ICU Monitoring:

Calculate SOFA daily
Increasing SOFA = worsening organ dysfunction (clinical deterioration)
Decreasing SOFA = improving organ function (responding to treatment)
Persistent high SOFA = ongoing multi-organ dysfunction, poor prognosis

3. Mortality Correlation:

SOFA 0-6: <10% mortality
SOFA 7-9: 15-20% mortality
SOFA 10-12: 40-50% mortality
SOFA 13-14: 50-60% mortality
SOFA 15-24: >80% mortality

Key insight: The change in SOFA (delta SOFA) over 24-48 hours is more predictive than the absolute score. A 2-3 point increase indicates high risk of death.

Strengths of SOFA Score

Dynamic tracking - serial measurements show clinical trajectory
Sepsis-3 standard - official sepsis definition uses SOFA
Organ-specific dysfunction - identifies which organs are failing
Simple calculation - only 6 variables, each 0-4 scale
No age bias - doesn't penalize elderly patients
Validated in sepsis - extensive evidence base for septic patients
Guides interventions - worsening scores trigger escalation of care
Daily monitoring - provides continuous feedback on treatment response

Limitations of SOFA Score

Requires daily calculation - more time-intensive than single assessment
Less accurate for admission prediction - designed for tracking, not initial prognosis
Cardiovascular component complex - requires vasopressor data (not always clear)
Doesn't include age/comorbidities - may underestimate risk in elderly or chronically ill
Subjective elements - GCS can vary between assessors
Better for sepsis than general ICU - validated primarily in septic populations

APACHE II: Acute Physiology and Chronic Health Evaluation II

What It Measures

APACHE II is a static ICU scoring system that predicts mortality risk based on a patient's severity of illness in the first 24 hours of ICU admission. It's calculated once and provides a snapshot of how sick the patient is at admission.

APACHE II was developed in 1985 (updated from original APACHE 1981) and remains the most widely used ICU severity score worldwide.

The Three Components

1. Acute Physiology Score (0-60 points) - 12 variables:

Temperature (rectal)
Mean arterial pressure (MAP)
Heart rate
Respiratory rate
Oxygenation (A-a gradient or PaO₂)
Arterial pH
Serum sodium
Serum potassium
Serum creatinine
Hematocrit
White blood cell count
Glasgow Coma Scale (15 - actual GCS)

2. Age Points (0-6 points):

<44 years: 0 points
45-54 years: 2 points
55-64 years: 3 points
65-74 years: 5 points
≥75 years: 6 points

3. Chronic Health Points (0-5 points):

If nonoperative or emergency postoperative: 5 points
If elective postoperative: 2 points
If no severe organ insufficiency or immunocompromised: 0 points

Chronic health conditions include:

Severe organ insufficiency (heart, lung, liver, kidney)
Immunocompromised state

Total APACHE II Score: 0-71 (sum of all three components)

How APACHE II is Used

1. Mortality Prediction:

| APACHE II Score | Predicted Mortality | |-----------------|---------------------| | 0-4 | 4% | | 5-9 | 8% | | 10-14 | 15% | | 15-19 | 25% | | 20-24 | 40% | | 25-29 | 55% | | 30-34 | 75% | | ≥35 | >85% |

2. ICU Admission Decision-Making:

High APACHE II (≥25) may guide goals of care discussions
Helps determine ICU vs step-down appropriateness
Identifies patients who may benefit from aggressive interventions vs palliative focus

3. Research and Benchmarking:

Standardizes ICU populations for clinical trials
Compares ICU outcomes across hospitals
Adjusts for case-mix when evaluating ICU performance

4. Resource Allocation:

Predicts ICU length of stay
Estimates need for mechanical ventilation
Informs staffing and capacity planning

Strengths of APACHE II Score

Strong mortality prediction - validated in hundreds of studies across ICU types
Admission snapshot - provides immediate prognostic information
Includes age and comorbidities - captures baseline health status
Widely used - international standard for ICU benchmarking
Generalizable - applies to medical, surgical, trauma, neurological ICU patients
Research standard - most common ICU severity score in clinical trials
No serial calculation needed - one assessment suffices

Limitations of APACHE II Score

Static score - doesn't track changes during ICU stay
Complex calculation - 34 data points, time-intensive
Age bias - penalizes elderly patients
Requires 24-hour data - can't be calculated immediately at admission
Not specific for sepsis - general ICU tool, not optimized for septic patients
Outdated calibration - developed in 1985, may overestimate mortality in modern ICUs
Doesn't guide daily management - useful for prognosis, not treatment monitoring

Key Differences: SOFA vs APACHE II

1. Timing: Sequential vs Single Assessment

SOFA: Calculated daily throughout ICU stay

Day 1 SOFA establishes baseline
Day 2, 3, 4… SOFA tracks trajectory
Delta SOFA (change from day 1 to day 3) predicts outcomes

APACHE II: Calculated once in first 24 hours

Provides admission severity snapshot
Not recalculated (unless readmission)
Doesn't capture clinical evolution

Clinical implication: Use SOFA to monitor "Is the patient getting better or worse?" Use APACHE II to answer "How sick is this patient at admission?"

2. Purpose: Monitoring vs Prognostication

SOFA: Designed to describe organ dysfunction and track it over time

Primary goal: quantify organ failure
Secondary goal: predict mortality (via serial scores)
Best for: sepsis monitoring, treatment response

APACHE II: Designed to predict mortality at admission

Primary goal: estimate death risk
Secondary goal: describe severity
Best for: admission decisions, research stratification

3. Components: Simple vs Complex

SOFA: 6 organ systems, 4-point scale (0-4) each

Respiration, coagulation, liver, cardiovascular, CNS, renal
No age factor
No chronic health factor
Total 24 variables (6 organs × 4 levels)

APACHE II: 12 physiological variables + age + chronic health

34 total data points
Includes age (0-6 points)
Includes comorbidities (0-5 points)
More granular (some variables have 5 levels of abnormality)

Clinical implication: SOFA is faster and simpler for daily use. APACHE II is more comprehensive but cumbersome for repeated measurements.

4. Sepsis Focus: Specific vs General

SOFA: Gold standard for sepsis

Sepsis-3 definition: Sepsis = infection + SOFA ≥2
qSOFA for bedside screening
Tracks multi-organ dysfunction (hallmark of sepsis)

APACHE II: General ICU tool

Applies to all ICU patients (medical, surgical, trauma, neuro)
Not specific for sepsis (though can be used)
Better for heterogeneous ICU populations

Clinical implication: For septic patients, SOFA is the standard. For mixed ICU populations or research, APACHE II is preferred.

5. Age and Comorbidities: Excluded vs Included

SOFA: No age or chronic health factors

Focuses purely on acute organ dysfunction
Doesn't penalize elderly or chronically ill patients
May underestimate mortality in older/sicker patients

APACHE II: Includes age and chronic health

Age adds 0-6 points (≥75 years = +6)
Chronic organ failure adds 0-5 points
Better captures baseline risk

Clinical implication: SOFA isolates acute illness severity. APACHE II considers both acute illness and baseline health.

6. Evidence Base: Sepsis-Specific vs Broad ICU

SOFA:

Strong evidence in sepsis (Sepsis-3 validation studies)
Moderate evidence in general ICU (less studied than APACHE)
Serial SOFA measurements improve prognostic accuracy

APACHE II:

Strong evidence across all ICU types (medical, surgical, trauma)
Hundreds of validation studies worldwide
Gold standard for ICU research and benchmarking

When to Use SOFA Score

Use SOFA for:

1. Sepsis Diagnosis and Monitoring

Sepsis-3 criteria: Infection + SOFA ≥2 increase = sepsis
Septic shock: Sepsis + vasopressors + lactate >2 mmol/L
qSOFA screening: RR ≥22, altered mentation, SBP ≤100 (bedside sepsis screening)

2. Daily ICU Rounding

Track organ dysfunction trends
Increasing SOFA → escalate care (vasopressors, mechanical ventilation, renal replacement therapy)
Decreasing SOFA → patient improving, consider de-escalation
Plateau SOFA → reassess treatment plan

3. Multi-Organ Failure

Identify which organs are failing (helps target interventions)
Quantify severity of organ dysfunction
Communicate severity to consultants and family

4. Treatment Response Assessment

Compare Day 1 vs Day 3 SOFA
Delta SOFA ≥2 increase = poor prognosis, consider goals of care discussion
Delta SOFA decrease = responding to treatment, continue current plan

5. Clinical Trials (Sepsis)

Enrollment criteria (e.g., "SOFA ≥2")
Endpoint measurement (change in SOFA over 7 days)
Subgroup analysis (high vs low SOFA)

When to Use APACHE II Score

Use APACHE II for:

1. ICU Admission Triage

APACHE II <10: Low risk, may be appropriate for step-down unit
APACHE II 10-19: Moderate risk, ICU appropriate
APACHE II 20-29: High risk, aggressive ICU care warranted
APACHE II ≥30: Very high mortality risk, discuss goals of care

2. Mortality Risk Prediction at Admission

Inform family discussions (predicted mortality %)
Guide goals of care (full code vs DNR/DNI vs comfort care)
Identify very high-risk patients (>75% predicted mortality)

3. Research and Benchmarking

Clinical trials: Stratify randomization by APACHE II
Quality improvement: Compare hospital ICU mortality to predicted mortality
Outcome research: Adjust for case-mix using APACHE II

4. Resource Planning

High APACHE II correlates with longer ICU stay
Predict mechanical ventilation duration
Estimate ICU bed days for capacity planning

5. Outcome Comparison Between ICUs

Standardized Mortality Ratio (SMR): Observed mortality / Expected mortality (based on APACHE II)
SMR <1: ICU performing better than expected
SMR >1: ICU performing worse than expected

Clinical Scenarios: Which Score to Use

Scenario 1: 65-Year-Old Septic Shock Patient, Day 1 ICU Admission

Use both:

Calculate APACHE II for admission mortality prediction (discuss prognosis with family)
Calculate SOFA (Day 1) to establish baseline organ dysfunction
Repeat SOFA daily to monitor treatment response

Example:

APACHE II = 22 (predicted mortality ~40%)
Day 1 SOFA = 12 (high baseline organ dysfunction)
Day 3 SOFA = 10 (improving - down 2 points, good sign)
Day 5 SOFA = 7 (continued improvement, likely to survive)

Scenario 2: 80-Year-Old Post-Operative Cardiac Surgery Patient, Stable Vital Signs

Use APACHE II:

Calculate admission severity (age + chronic health + acute physiology)
APACHE II accounts for age and surgical stress
Guides ICU vs step-down decision
Don't use SOFA (no organ dysfunction, score would be 0-2, not useful for tracking)

Scenario 3: 45-Year-Old Trauma Patient, Multi-Organ Injury, ICU Day 5

Use SOFA:

Serial SOFA tracks recovery from acute injuries
Day 1 SOFA = 14 (high baseline)
Day 5 SOFA = 11 (slowly improving)
APACHE II less useful (already past first 24 hours, not recalculated)

Scenario 4: ICU Research Study Comparing Two Sepsis Treatments

Use both:

APACHE II for baseline severity matching (ensure groups are comparable)
SOFA as primary outcome (change in SOFA from Day 1 to Day 7)
Delta SOFA (improvement in organ dysfunction) is common sepsis trial endpoint

Scenario 5: Hospital Quality Improvement Project, Comparing ICU Outcomes to National Benchmarks

Use APACHE II:

Calculate predicted mortality for all ICU admissions
Compare observed mortality to APACHE II predicted mortality
Compute Standardized Mortality Ratio (SMR)
Identify opportunities for improvement

Scenario 6: 70-Year-Old Septic Patient, Day 3 ICU, Not Improving

Use SOFA:

Day 1 SOFA = 10
Day 3 SOFA = 12 (worsening - +2 points)
Delta SOFA +2 = poor prognosis, consider:
- Escalate treatment (increase vasopressor support, consider dialysis)
- Goals of care discussion (expected mortality >60%)
- Family meeting to discuss prognosis

Can You Use Both Together?

Yes, and this is often the best approach:

Complementary Roles

APACHE II at admission:

Establishes baseline severity
Predicts overall mortality risk
Informs initial goals of care discussion
Provides context for expected outcome

SOFA daily:

Tracks organ dysfunction trajectory
Monitors treatment response
Identifies deterioration or improvement
Guides daily clinical decisions

Combined Prognostic Power

Recent research shows combining SOFA and APACHE II improves mortality prediction:

APACHE II alone: AUROC 0.75-0.85
Serial SOFA alone: AUROC 0.75-0.80
APACHE II + Delta SOFA (Day 1 to Day 3): AUROC 0.85-0.90

Best approach:

Day 1: Calculate both APACHE II and SOFA
Days 2-7: Calculate SOFA daily
Day 3: Calculate Delta SOFA (SOFA Day 3 - SOFA Day 1)
- Delta SOFA >+2: high mortality risk
- Delta SOFA -2 or more: good prognosis
Use together: APACHE II + Delta SOFA gives most accurate prognosis

Evidence: Which is Better?

General ICU Population

Winner: APACHE II

More validated studies in mixed ICU populations
Better admission mortality prediction (AUROC 0.80-0.85)
Standard for ICU benchmarking

Sepsis Patients

Winner: SOFA

Sepsis-3 guidelines use SOFA (not APACHE II)
Better for tracking sepsis organ dysfunction
Serial SOFA (mean, max, delta) outperforms APACHE II for sepsis outcomes

Mortality Prediction

Tie:

APACHE II: Better at admission (single score)
SOFA: Better with serial measurements (mean SOFA, max SOFA, delta SOFA)

Clinical Utility

Winner: SOFA

Easier to calculate daily (simpler, fewer variables)
Provides actionable information (which organs are failing?)
Guides daily treatment decisions

Research and Benchmarking

Winner: APACHE II

International standard for ICU research
Widely used for hospital performance comparisons
Validated in hundreds of studies

Key Takeaways

✅ SOFA is dynamic (daily), APACHE II is static (once at admission)

✅ Use SOFA for sepsis - Sepsis-3 definition requires SOFA ≥2 increase

✅ Use APACHE II for admission mortality prediction - tells you how sick the patient is at the start

✅ SOFA tracks treatment response - increasing SOFA = getting worse, decreasing SOFA = improving

✅ APACHE II includes age and comorbidities, SOFA does not - APACHE II better captures baseline health

✅ SOFA is simpler (6 organ systems), APACHE II is complex (34 variables)

✅ Serial SOFA measurements are more predictive - delta SOFA (change over 48-72 hours) predicts outcomes

✅ Use both together for best results - APACHE II at admission + daily SOFA gives most complete picture

✅ SOFA guides daily clinical decisions, APACHE II guides admission triage and goals of care

✅ Both predict mortality, but SOFA is better for sepsis-specific populations

Related Tools

SOFA Score Calculator - Sequential Organ Failure Assessment (daily ICU scoring)
APACHE II Calculator - Acute Physiology and Chronic Health Evaluation (admission severity)
qSOFA Calculator - Quick SOFA for bedside sepsis screening
ICU Scoring Systems Guide - Complete guide to SOFA, APACHE II, SAPS II, and more

Sources

Disclaimer: SOFA and APACHE II scores are clinical decision tools for healthcare professionals in intensive care settings. They are not substitutes for clinical judgment and should be used as part of comprehensive patient assessment. These tools are for educational and informational purposes only.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.